Table 2.
Parameter Estimates for the Final Best Model Describing the Kinetics of NAb
| Parameter | Value | Standard Error | % Relative Standard Error |
|---|---|---|---|
| Fixed effects | |||
| N0 | 96.05 | 1.690 | 1.76 |
| kel1 | 0.017 | 0.001 | 8.48 |
| beta_kel1_Age* | 0.020 | 0.002 | 9.27 |
| kel2 | 0.111 | 0.008 | 7.63 |
| kel3 | 0.071 | 0.007 | 9.16 |
| Standard deviation of the random effects | |||
| omega_N0 | 0.016 | 0.002 | 12.8 |
| omega_kel1 | 1.37 | 0.099 | 7.25 |
| omega_kel2 | 0.98 | 0.067 | 6.86 |
| omega_kel3 | 1.10 | 0.081 | 7.36 |
| Correlations | |||
| corr_kel2_kel1 | 0.78 | 0.037 | 4.68 |
| Error model parameters | |||
| b | 0.043 | 0.001 | 2.79 |
*Indicates a statistically significant (P = 0.0037 < 0.05) contribution of “age” as a covariate to the first-phase elimination rate constant.
b = the proportional error term of the model residual variability; beta_kel1_Age = constant for the contribution of “age” on kel1; corr_kel2_kel1 = the correlation coefficient between kel1 and kel2; kel1 = elimination rate constant of the first trimester (zero to third month); kel2 = elimination rate constant of the second trimester (third to sixth month); kel3 = elimination rate constant of the third trimester (sixth to ninth month); NAbs = neutralizing antibodies; N0 = average initial NAbs value; omega = between-subject variability estimate for each parameter.